Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

1.76
-0.1200-6.38%
Post-market: 1.790.0300+1.70%19:55 EDT
Volume:133.33K
Turnover:233.60K
Market Cap:2.89M
PE:-0.15
High:1.82
Open:1.80
Low:1.71
Close:1.88
Loading ...
Oct 20, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 28, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 18, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Jun 03, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Correspondence

Form CORRESP - Correspondence
May 09, 2023

Correspondence

Form CORRESP - Correspondence
May 09, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 08, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 28, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Apr 10, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 30, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2023

Major Issues Report

8-K - Current report
Mar 24, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals